Resting myocardial ischemia after intravenous infusion of BM 13.177 (sulotroban), a thromboxane receptor antagonist.
Terres
W
W
Department of Cardiology, Eppendorf University Hospital, Hamburg, West-Germany.
Kupper
W
W
Hamm
C W
CW
Bleifeld
W
W
D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000139:chemically induced / Q000503:physiopathology*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D011982:Receptors, Prostaglandin / Q000187:drug effects*; D017482:Receptors, Thromboxane; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000502:physiology*
D005343:Fibrinolytic Agents; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D013449:Sulfonamides; D013928:Thromboxane A2; C040624:sulotroban